Application of Preoperative Selective Portal Vein Embolization in Hepatocellular Carcinoma Hepatectomy

LUO Zhi-qiang,WU Lin-quan,SHAO Jiang-hua,GUO Wu-hua,ZHOU Fan,HUANG Ming-wen,WANG Kai
DOI: https://doi.org/10.3969/j.issn.1000-2294.2011.01.013
2011-01-01
Abstract:Objective To study the effect of preoperative selective portal vein embolization(SPVE) on the changes in liver volume and the second-stage hepatectomy in patients with hepatocellular carcinoma(HCC) who were considered inoperable because of insufficient residual liver volume.Methods Eleven patients with HCC who were not suitable for hepatectomy were treated by DSA-guided percutaneous transhepatic SPVE with fine needles.The rate of success,adverse reactions,the volume of each liver lobe,the ratio of residual liver volume to total liver volume(RLV/TLV),and hepatectomy rate were observed.Results SPVE was successfully performed in all 11 patients.In patients with right portal vein branch embolization,the right liver volume decreased while left liver volume increased gradually.RLV/TLV increased from 34.5% preoperatively to 37.9%,41.6% and 45.6% at 1,2 and 3 weeks postoperatively.The adverse reactions included hepatic function impairment with transient elevation of hepatic enzyme(11 cases),different degrees of pain in liver area(4 cases) and lower fever(6 cases).At postoperative week 4,the second-stage hepatectomy was successfully completed in all patients.No operative mortality and severe complications,such as ectopic embolization,liver failure,bleeding,bile leakage and infection,occured during therapy.Conclusion Preoperative SPVE is a safe and effective procedure,and can increase the indications of hepatectomy for huge HCC and elevate the security of hepatectomy.
What problem does this paper attempt to address?